2-Ethylphenylboronic Acid | CAS:90002-36-1

We serve 2-Ethylphenylboronic Acid CAS:90002-36-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Ethylphenylboronic Acid

Product Name: 2-Ethylphenylboronic Acid
Other Name:
2-Ethylphenylboronic Acid
(2-ethylphenyl)boronic acid
CAS No: 90002-36-1
MF: C8H11BO2
MW: 149.98300
Density: 1.07 g/cm3
Boiling point: 299.1ºC at 760 mmHg
Melting point: 102.5-107.5 °C(lit.)
Flash point: 134.7ºC
Refractive index: 1.521
UN Number: Non-dangerous goods
Transport hazard class: Non-dangerous goods
Packing group: Non-dangerous goods
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2-Ethylphenylboronic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2-ethylphenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2-ethylphenyl)boronic acid Use and application,(2-ethylphenyl)boronic acid technical grade,usp/ep/jp grade.


Related News: Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.1-[2-Amino-1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride manufacturer China’s pharmaceutical CMO market has recently maintained a growth rate of more than 10%. From the perspective of market structure, the average growth rate of clinical production is 9.5%, while the average growth rate of commercial production will reach 18.7%.2,6-Diamino-9-(β-D-arabinofuranosyl)purine supplier API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.L-Alanyl-L-Glutamine vendor “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.There’s a few factors that play into this.